arrow
Q

Qing Mao

Shenyang Pharmaceutical University
H指数:15
被引数:526

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, Synthesis, and Biological Evaluation of 4-(Difluoromethyl)-1H-imidazole-5-carboxylic Acids/4-(3-Cyanophenoxy)pyrimidine-5-carboxylic Acids as P2Y1 Receptor Antagonists for Ischemic Stroke Treatment

4-(二氟甲基)-1H-咪唑-5-甲酸/4-(3-氰苯氧基)嘧啶-5-甲酸的设计、合成及其作为缺血性卒中治疗用P2Y1受体拮抗剂的生物评价

2025-05-150
PRE
Scaffold hopping-based structural modification of tranilast led to the identification of HNW005 as a promising NLRP3 inflammasome and URAT1 dual inhibitor for the treatment of gouty arthritis

基于骨架跃迁的结构修饰对曲尼司特进行了改造,从而发现了HNW005,它是一种有前景的NLRP3炎性小体和URAT1双抑制剂,可用于治疗痛风性关节炎。

2025-05-100
PRE
Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/ 6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors

N-(3-氰基-1h-吲哚-5/ 6-基)-6-氧代-1,6-二氢嘧啶-4-甲酰胺和5-(6-氧代-1,6-二氢嘧啶-2-基)-1h-吲哚-3-腈作为新型黄嘌呤氧化酶抑制剂的设计,合成和生物学评价

2022-01-0122
PRE
Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives

靶向黄嘌呤氧化酶中的子口袋: 2-[4-烷氧基-3-(1h-四唑-1-基) 苯基]-6-氧代-1,6-二氢嘧啶-5-羧酸衍生物的设计,合成和生物学评估

2019-11-0134
PREAI
Discovery of 1-Difluoromethyl-3-(3-cyanophenyl)-6-[4-(trifluoromethoxy)phenyl]imidazo[1; 5-a]pyrazin-8-(7H)-one as a Potent P2Y1 Antagonist for the Treatment of Ischemic Stroke and Myocardial Infarction

1-二氟甲基-3-(3-氰基苯基)-6-[4-(三氟甲氧基)苯基]咪唑并[1;5-a]吡嗪-8-(7H)-酮作为治疗缺血性中风和心肌梗死的强效P2Y1拮抗剂的发现

0
PRE